연구성과 홍보

Genomics Inform. 2025 May 20;23(1):14.

Title : Non-variable RNA deletion using the CRISPR-Cas9 technique demonstrated improved outcomes in human intestine single-cell RNA sequencing data, even at half sequencing depths

Authors : Dong Jun Kim1,2,3, Christine Suh Yun Joh1,2, So Young Jeong1,2, Yong Jun Kim1,2, Seong Joon Koh4, Hyun Je Kim5,6,7,8,9*

Affiliations :

1Department of Biomedical Sciences, Seoul National University Graduate School, Seoul, 03080, Republic of Korea.

2Department of Microbiology and Immunology, Seoul National University College of Medicine, Seoul, 03080, Republic of Korea.

3Cancer Research Institute, Seoul National University College of Medicine, Seoul, 03080, Republic of Korea.

4Department of Internal Medicine and Liver Research Institute, Medical Research Center, Seoul National University College of Medicine, Seoul, 03080, Republic of Korea.

5Department of Biomedical Sciences, Seoul National University Graduate School, Seoul, 03080, Republic of Korea.

6Department of Microbiology and Immunology, Seoul National University College of Medicine, Seoul, 03080, Republic of Korea.

7Cancer Research Institute, Seoul National University College of Medicine, Seoul, 03080, Republic of Korea.

8Genomic Medicine Institute, Seoul National University College of Medicine, Seoul, 03080, Republic of Korea.

9Interdisciplinary Program in Artificial Intelligence (IPAI), Seoul National University, Seoul, 08826, Republic of Korea.

DOI: 10.1186/s44342-025-00043-6.

Abstract :

In single-cell RNA sequencing (scRNA-seq) data, issues related to the high expression of non-variable RNAs often arise due to organ traits or sample quality. Computational methods, such as SoupX (Young (Gigascience 9:giaa151, 2020)), have been used to solve this problem but it may remove biologically relevant data. This study presents a clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9-based method that selectively removes non-variable RNAs. We applied this approach to scRNA-seq data from human intestinal tissues of 17 patients. By targeting non-variable genes, including ribosomal and mitochondrial RNAs, CRISPR-Cas9 treatment effectively reduced their expression, outperforming computational methods in both the number and extent of gene removal. The CRISPR-Cas9 treated samples, sequenced at half the depth compared to untreated samples, maintained comparable sequencing quality, and saturation, demonstrating that this approach can reduce sequencing costs while preserving data quality. Cell type composition and gene expression patterns remained consistent between treated and original datasets, with no unintended gene deletions. Overall, our findings suggest that the CRISPR-Cas9-based method offers a cost-effective solution for improving scRNA-seq data quality, particularly for tissues with high levels of non-variable RNAs, without compromising biological integrity.